Far Eastern Memorial Hospital   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Banqiao Taiwan (1981)

Organization Overview

First Clinical Trial
2000
NCT00166881
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Chih-Wei Tang | Department of Internal Medicine, Far Eastern Memorial Hospital | Family Medicine department | Family Medicine Department | Far Eastern Memorial Hospital | Far Eastern Memorial Hospital, Taipei, Taiwan | Far Eastern Memorial Hospital, Taiwan

Active Ingredients

Drugs in Phase 4 Trials (32)

23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)

acetylcysteine (mucomyst) (3 trials)

alendronic acid (fosamax) (1 trial)

beclomethasone (vanceril) (1 trial)

ceftriaxone (rocephin) (1 trial)

cilostazol (pletal) (1 trial)

dexamethasone (1 trial)

entecavir (baraclude) (2 trials)

esomeprazole (nexium) (1 trial)

estradiol (progynon depot) (1 trial)

famotidine (pepcid) (2 trials)

fluticasone (cutivate) (3 trials)

formoterol (foradil) (1 trial)

hydrocortisone (solu-cortef) (1 trial)

interferon alpha-2b (Intron-A) (6 trials)

lansoprazole (prevacid) (1 trial)

lorazepam (ativan) (1 trial)

medroxyprogesterone (provera) (1 trial)

mirabegron (myrbetriq) (3 trials)

olmesartan (benicar) (1 trial)

omeprazole (prilosec) (1 trial)

pantoprazole (protonix) (1 trial)

pentoxifylline (trental) (1 trial)

propofol (diprivan) (1 trial)

ranibizumab (lucentis) (1 trial)

ribavirin (virazole) (3 trials)

salmeterol (serevent) (2 trials)

telmisartan (micardis) (1 trial)

thiamine (1 trial)

tibolone (xyvion) (1 trial)

valsartan (diovan) (1 trial)

vitamin c (1 trial)

Drugs in Phase 3 Trials (7)

citalopram (celexa) (1 trial)

danazol (danocrine) (1 trial)

dienogest (natazia) (1 trial)

duloxetine (Cymbalta) (2 trials)

imipramine (tofranil) (2 trials)

quadrivalent groups a, c, y, and w-135 meningococcal vaccine (Menomune-A/C/Y/W-135) (1 trial)

solifenacin (vesicare) (2 trials)

Drugs in Phase 2 Trials (14)

cetuximab (erbitux) (1 trial)

cisplatin (platinol) (3 trials)

docetaxel (taxotere) (3 trials)

fluorouracil (efudex) (2 trials)

gemcitabine (gemzar) (1 trial)

imatinib (gleevec) (1 trial)

irinotecan (Camptosar) (1 trial)

leucovorin (2 trials)

lipotecan (1 trial)

paclitaxel (taxol) (1 trial)

tegafur (1 trial)

temozolomide (temodar) (1 trial)

thalidomide (Thalomid) (1 trial)

uracil (1 trial)

Drugs in Phase 1 Trials (1)

autologous mesenchymal stem cells (1 trial)

Drugs in Other Trials (8)

benzathine penicillin (1 trial)

bictegravir (Biktarvy) (1 trial)

doxycycline (vibramycin) (1 trial)

emtricitabine (emtriva) (1 trial)

lidocaine (xylocaine) (1 trial)

tenofovir alafenamide (genvoya) (1 trial)

tolterodine (detrol) (1 trial)

whey protein (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Kidney Injury (Phase 4)

Asthma (Phase 4)

Atherosclerosis (Phase 4)

Brain Neoplasms (Phase 2)

Breast Neoplasms (Phase 2)

Calcinosis (Phase 4)

Carcinoma (Phase 2)

Carcinoma, Hepatocellular (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Cardiovascular Diseases (Phase 4)

Cerebral Infarction (Phase 4)

Congenital Abnormalities (Phase 4)

Edema (Phase 4)

Enuresis (Phase 3)

Esophageal and Gastric Varices (Phase 4)

Gastrointestinal Hemorrhage (Phase 4)

Heart Arrest (Phase 4)

Hemorrhage (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Hypothermia (Phase 4)

Inflammation (Phase 4)

Ischemia (Phase 4)

Kidney Diseases (Phase 4)

Kidney Failure, Chronic (Phase 4)

Lower Urinary Tract Symptoms (Phase 4)

Lung Diseases (Phase 4)

Lung Diseases, Obstructive (Phase 4)

Lung Neoplasms (Phase 2)

Macular Edema (Phase 4)

Meningitis (Phase 3)

Meningitis, Bacterial (Phase 3)

Neoplasm Metastasis (Phase 2)

Neoplasms, Second Primary (Phase 2)

Osteoarthritis (Phase 1)

Osteoarthritis, Knee (Phase 1)

Peptic Ulcer (Phase 4)

Peripheral Arterial Disease (Phase 4)

Peripheral Vascular Diseases (Phase 4)

Psychophysiologic Disorders (Phase 4)

Pulmonary Disease, Chronic Obstructive (Phase 4)

Renal Insufficiency (Phase 4)

Renal Insufficiency, Chronic (Phase 4)

Respiratory Insufficiency (Phase 4)

Sepsis (Phase 4)

Somatoform Disorders (Phase 4)

Stomach Neoplasms (Phase 2)

Stomach Ulcer (Phase 4)

Stroke (Phase 4)

Syndrome (Phase 4)

Ulcer (Phase 4)

Urinary Bladder, Overactive (Phase 4)

Urinary Incontinence (Phase 3)

Urinary Incontinence, Stress (Phase 3)

Vascular Calcification (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 50
  • # of Trial APIs: 62